EPIDEMIOLOGICAL ANALYSIS OF ADMISSIONS FOR ACUTE MYOCARDIAL INFARCTION IN THE STATE OF PIAUÍ FROM 2014 TO 2023

• DOI: https://doi.org/10.22533/at.ed.1594742408081

• Palavras-chave: Epidemiology, Acute myocardial infarction, Morbidity, Mortality. Biostatistics

• Keywords: Epidemiology, Acute myocardial infarction, Morbidity, Mortality. Biostatistics

• Abstract:

  Brazil, although still developing, has sociodemographic and health characteristics similar to those of developed countries, such as a predominance of chronic non-communicable diseases, among which Acute Myocardial Infarction (AMI) is one of the biggest causes of morbidity and mortality in the national territory. The study aimed to analyze the epidemiology of hospitalizations for AMI in the state of Piauí from 2014 to 2023. The research used a documentary, observational, retrospective descriptive and qualitative-quantitative epidemiological approach. Data were collected from the Hospital Morbidity Information System (SIH/SUS) via DATASUS, covering hospitalizations for AMI in Piauí from 2014 to 2023. The variables studied included age group, sex, race, nature of hospitalization and number of deaths. The data were organized in Excel® spreadsheets and analyzed using descriptive statistics. The highest number of cases was registered in 2022 (11.84%). The majority of cases were men (64.28%) and aged between 60 and 69 years (29.53%). The brown race predominated among the cases (49.67%). The majority of hospitalizations occurred urgently (93%). There was an annual average of 135.9 deaths, with 2022 recording the highest number (161 deaths, 11.85%). The data indicate a growing trend in hospitalizations for AMI in Piauí, especially in 2022. The epidemiological profile of those hospitalized is mostly made up of brown men aged 60 to 69 years. The high proportion of emergency admissions reflects the severity of the AMI. Stability in annual mortality suggests a continued need for improvements in prevention and treatment strategies. This study highlights the importance of interventions targeting cardiovascular risk factors to reduce morbidity and mortality associated with AMI.